Skip to content

prospective, observational registration study for women with Inflammatory breast cancer

INFLAME: Towards optimal treatment of inflammatory breast cancer patients A study of the Dutch Breast Cancer Research Group (BOOG); BOOG 2014-05

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON28954
Enrollment
200
Registered
2015-03-06
Start date
2015-02-06
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Breast Cancer, INFLAME, IBC

Interventions

None listed

Sponsors

BOOG (the PI of the study is from University Medical Center Groningen)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: - Gender: female - Diagnosis: primary IBC (all stages of the disease) - Age: ¡Ý18 years old at time of diagnosis - Mental competence and understanding of the Dutch language are required.

Exclusion criteria

Exclusion criteria: potential subject being incapacitated or for any reason unable to provide informed consent will be excluded from participation in this study.

Contacts

Public ContactC.P. Schröder

Hanzeplein 1

c.p.schroder@umcg.nl050 – 3616161 (pieper 77530)

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)